ANHIM
VRTX icon

Alan N. Hoffman Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Alan N. Hoffman Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+440
New +$195K 0.13% 14
2025
Q2 		– Sell
-440
Closed -$213K – 15
2025
Q1 		$213K Buy
+440
New +$205K 0.11% 14
2024
Q4 		– Sell
-440
Closed -$205K – 14
2024
Q3 		$205K Hold
440
– – 0.1% 14
2024
Q2 		$206K Buy
+440
New +$191K 0.1% 14

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Alan N. Hoffman Investment Management's VRTX Position: Q2 2026 in Review

Alan N. Hoffman Investment Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 440 shares worth $219K. The stake represents 0.13% of the portfolio and ranks #14 among its holdings. This is a return to the name: Alan N. Hoffman Investment Management previously reported a position in VRTX as recently as Q1 2025.

Alan N. Hoffman Investment Management first reported a position in VRTX in Q2 2024 and has held it in 4 quarters since. 734 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Alan N. Hoffman Investment Management held 440 shares of Vertex Pharmaceuticals worth $219K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Alan N. Hoffman Investment Management position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.13% of Alan N. Hoffman Investment Management's portfolio in Q2 2026, its #14 holding.
  • Alan N. Hoffman Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 734 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alan N. Hoffman Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.